Home/Filings/4/0001562180-21-007610
4//SEC Filing

Anderson Harvey 4

Accession 0001562180-21-007610

CIK 0000047217other

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 6:00 PM ET

Size

26.0 KB

Accession

0001562180-21-007610

Insider Transaction Report

Form 4
Period: 2021-12-07
Anderson Harvey
Chief Legal Officer & Sec
Transactions
  • Exercise/Conversion

    Common Stock

    2021-12-07+38,09238,092 total
  • Award

    Restricted Stock Units

    2021-12-07+34,32634,326 total
    Common Stock (34,326 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2021-12-0715,18229,561 total
    Common Stock (15,182 underlying)
  • Award

    Performance Restricted Stock Units

    2021-12-07+19,82919,829 total
    Common Stock (19,829 underlying)
  • Tax Payment

    Common Stock

    2021-12-07$37.29/sh18,890$704,40819,202 total
  • Award

    Performance-Contingent Stock Options

    2021-12-07+91,16291,162 total
    Exercise: $37.29Common Stock (91,162 underlying)
  • Sale

    Common Stock

    2021-12-09$36.02/sh8,268$297,81310,934 total
  • Exercise/Conversion

    Restricted Stock Units

    2021-12-076,50712,669 total
    Common Stock (6,507 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2021-12-0710,4119,756 total
    Common Stock (10,411 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2021-12-075,9920 total
    Common Stock (5,992 underlying)
Footnotes (10)
  • [F1]Shares withheld by HP to satisfy tax withholding upon vesting.
  • [F10]As previously reported, on 12/7/2018, the reporting person was granted 16,354 RSUs, 5,451 of which vested on each of 12/7/2019 and 12/7/2020 and 5,452 of which vested on 12/7/2021. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 540 vested dividend equivalent rights.
  • [F2]The sales reported on this Form 4 were executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/29/2020 .
  • [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock.
  • [F4]On 12/7/2021, the reporting person was granted 34,326 RSU, one-third of which vest annually over three years on each of 12/7/2022, 12/7/2023 and 12/7/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock.
  • [F5]On 12/7/2021, the reporting person was granted 19,829 Performance Adjusted Restricted Stock Units ("PARSUs"), 100% of which will only be earned after certification of financial results as of 10/31/2024, subject to certain earnings per share and relative total stockholder return conditions being met as of that date. Dividend equivalent rights accrue with respect to these PARSUs when and as dividends are paid on HP common stock.
  • [F6]The performance contingent stock options granted on 12/7/2021 will vest 33.3% on each of the first two anniversaries of the grant date, and 33.4% on the third anniversary, in each case subject to the satisfaction of certain stock price performance conditions.
  • [F7]As previously reported, on 12/7/2020, the reporting person was granted 19,003 RSUs, 6,334 of which vested on 12/7/2021, 6,334 of which is scheduled to vest on 12/7/2022 and 6,335 of which is scheduled to vest on 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 173 vested dividend equivalent rights.
  • [F8]As previously reported, on 12/7/2020, the reporting person was granted 44,341 RSUs, 14,780 of which vested on 12/7/2021, 14,780 of which is scheduled to vest on 12/7/2022 and 14,781 of which is scheduled to vest on 12/7/2023. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 402 vested dividend equivalent rights.
  • [F9]As previously reported, on 12/6/2019, the reporting person was granted 29,268 RSUs, 9,756 of which vested on 12/7/2020 and 12/7/2021, and 9,756 of which is scheduled to vest on 12/7/2022. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 655 vested dividend equivalent rights.

Issuer

HP INC

CIK 0000047217

Entity typeother

Related Parties

1
  • filerCIK 0001842375

Filing Metadata

Form type
4
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 6:00 PM ET
Size
26.0 KB